CYTEK BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CYTEK BIOSCIENCES, INC. (CTKB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 301.49 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 301.49K shares, a 27.38% increase year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 0.00 shares.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 236.69K shares, a 26.14% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 320.45K shares, a 11.95% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 363.94K shares, a 43.23% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 641.04K shares, a 53.43% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 301.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 301.49K shares 10-Q · filed 2026-08-05 | 301.49K shares derived: sum of 3 quarters · filed 2026-08-05 | 301.49K shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-07 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-07 | 236.69K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-26 | 236.69K shares derived: sum of 3 quarters · filed 2026-02-26 | 236.69K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 236.69K shares derived: sum of 2 quarters · filed 2025-11-05 | 236.69K shares 10-Q · filed 2025-11-05 | 241.84K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | 236.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 236.69K shares 10-Q · filed 2025-08-06 | 241.84K shares derived: sum of 3 quarters · filed 2026-02-26 | 461.93K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | 5.15K shares derived: sum of 2 quarters · filed 2026-02-26 | 225.24K shares derived: sum of 3 quarters · filed 2026-02-26 | 253.26K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | 5.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 225.24K shares derived: sum of 2 quarters · filed 2026-02-26 | 253.26K shares derived: sum of 3 quarters · filed 2026-02-26 | 320.45K shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 220.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 248.11K shares derived: sum of 2 quarters · filed 2024-11-07 | 315.30K shares 10-Q · filed 2024-11-07 | 341.48K shares derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-06-30 | 28.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 95.21K shares 10-Q · filed 2024-08-06 | 121.39K shares derived: sum of 3 quarters · filed 2025-02-28 | 293.80K shares derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | 67.18K shares 10-Q · filed 2024-05-08 | 93.37K shares derived: sum of 2 quarters · filed 2025-02-28 | 265.77K shares derived: sum of 3 quarters · filed 2025-02-28 | 383.08K shares derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | 26.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 198.59K shares derived: sum of 2 quarters · filed 2025-02-28 | 315.90K shares derived: sum of 3 quarters · filed 2025-02-28 | 363.94K shares 10-K · filed 2025-02-28 |
| 2023-09-30 | 172.41K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 289.72K shares derived: sum of 2 quarters · filed 2023-11-14 | 337.75K shares 10-Q · filed 2023-11-14 | 414.84K shares derived: sum of 4 quarters · filed 2024-03-13 |
| 2023-06-30 | 117.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 165.35K shares 10-Q · filed 2023-08-08 | 242.43K shares derived: sum of 3 quarters · filed 2024-03-13 | 269.59K shares derived: sum of 4 quarters · filed 2024-03-13 |
| 2023-03-31 | 48.04K shares 10-Q · filed 2023-05-09 | 125.12K shares derived: sum of 2 quarters · filed 2024-03-13 | 152.28K shares derived: sum of 3 quarters · filed 2024-03-13 | 251.49K shares derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-12-31 | 77.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 104.24K shares derived: sum of 2 quarters · filed 2024-03-13 | 203.45K shares derived: sum of 3 quarters · filed 2024-03-13 | 641.04K shares 10-K · filed 2024-03-13 |
| 2022-09-30 | 27.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 126.36K shares derived: sum of 2 quarters · filed 2022-11-09 | 563.95K shares 10-Q · filed 2022-11-09 | 687.02K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-06-30 | 99.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 536.80K shares 10-Q · filed 2022-08-10 | 659.87K shares derived: sum of 3 quarters · filed 2023-03-01 | 707.54K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-03-31 | 437.59K shares 10-Q · filed 2022-05-12 | 560.66K shares derived: sum of 2 quarters · filed 2023-03-01 | 608.33K shares derived: sum of 3 quarters · filed 2023-03-01 | |
| 2021-12-31 | 123.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 170.75K shares derived: sum of 2 quarters · filed 2023-03-01 | 417.80K shares 10-K · filed 2023-03-01 | |
| 2021-09-30 | 47.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 294.73K shares 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | 247.05K shares 10-Q · filed 2021-09-03 | |||
| 2020-12-31 | 37.06K shares 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |